AcetaMide, N-(4-broMo-2-nitrophenyl)-2-chloro-
|
- $251 - $500.87
- Product name: AcetaMide, N-(4-broMo-2-nitrophenyl)-2-chloro-
- CAS: 854583-85-0
- MF: C8H6BrClN2O3
- MW: 293.5
- EINECS:
- MDL Number:MFCD07468929
- Synonyms:AcetaMide, N-(4-broMo-2-nitrophenyl)-2-chloro-;N-(4-BroMo-2-nitrophenyl)-2-chloroacetaMide
4 prices
Selected condition：
Brand
- AK Scientific
- Alichem
- American Custom Chemicals Corporation
- Crysdot
Package
- 5MG
- 1g
- 5g
- ManufacturerAK Scientific
- Product numberV8101
- Product descriptionN-(4-Bromo-2-nitrophenyl)-2-chloroacetamide
- Packaging1g
- Price$251
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number854583850
- Product descriptionN-(4-Bromo-2-nitrophenyl)-2-chloroacetamide
- Packaging5g
- Price$423.72
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0353923
- Product descriptionN-(4-BROMO-2-NITROPHENYL)-2-CHLOROACETAMIDE 95.00%
- Packaging5MG
- Price$500.87
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12023917
- Product descriptionN-(4-Bromo-2-nitrophenyl)-2-chloroacetamide 95+%
- Packaging5g
- Price$424
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | V8101 | N-(4-Bromo-2-nitrophenyl)-2-chloroacetamide | 1g | $251 | 2021-12-16 | Buy |
| Alichem | 854583850 | N-(4-Bromo-2-nitrophenyl)-2-chloroacetamide | 5g | $423.72 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | HCH0353923 | N-(4-BROMO-2-NITROPHENYL)-2-CHLOROACETAMIDE 95.00% | 5MG | $500.87 | 2021-12-16 | Buy |
| Crysdot | CD12023917 | N-(4-Bromo-2-nitrophenyl)-2-chloroacetamide 95+% | 5g | $424 | 2021-12-16 | Buy |
Properties
Boiling point :446.8±45.0 °C(Predicted)
Density :1.812±0.06 g/cm3(Predicted)
pka :10.73±0.70(Predicted)
Density :1.812±0.06 g/cm3(Predicted)
pka :10.73±0.70(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|